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Abstract: Medicines obtained from drug plants and other sources are commonly called traditional medicines. They
have played an important role in the treatment of several human diseases since ancient times. India possessed a
great wealth of traditional health care system known as Ayurveda related to the use of plant species. The global
market of herbal drugs has a great potential around the world. Demand of plant based medicines is also increasing
among western countries because of a general consideration that most allopathic drugs are associated with more
or less side effects. Many pharmaceutical companies are now manufacturing Ayurvedic phytopharmaceutical
products. However, enough efforts have not been made to get suitable substitute of modern allopathic medicines
from these traditionally used drug plants and herbal drugs. This traditional system of healthcare in India still needs
extensive evidence-based scientific researches in promoting its therapies. This review paper deals with modern
scientific approaches to  find out new plant based molecules and to develop new technologies in a continuous
process and should be applied in the practice to improve the quality of herbal drugs in Indian pharmaceutical
industries. Critical assessment of quality assurance including researches on pharmacognosy, chemistry,
pharmacology, antimicrobial activity and clinical studies carried out on various Ayurvedic medicinal plants are also
being presented.
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INTRODUCTION
Diseases and death of human beings has been a natural
phenomenon since the evolution of humans on earth.
They have always made an effort to keep them healthy
and disease free by using different substances
distributed in the nature around them. Plants being earlier
than man on the planet are not only the source of food
and shelter but also have become a powerful source of
remedies for a large number of human diseases.
According to World Health Organization (WHO, 1978),
“a medicinal plant is any plant which, in one or more of
its organs, contains substances that can be used for
therapeutic purposes, or which are precursors for chemo-
pharmaceutical semi-synthesis”. The traditional systems
of medicine are still considered as a great knowledge
based in herbal medicines (Singh and Lal, 2008). The
medicinal plants have regained a wide recognition to
combat infectious diseases due to the failure of modern
drugs against various chronic diseases along with
increasing costs and side effects associated with them.
Emergence of multi-drug resistant strains of pathogenic
bacteria and higher safety margins also contribute
towards increasing interest in traditional medicine.
Phytochemicals have contributed significantly to the
development of new drugs from medicinal plants (Cox,
1990; Veale et al., 1992; Eisenberg et al., 1993; Cox and
Balick, 1994; Prance, 1994; Samy, et al., 2008).
Ethnobotanical studies have also brought to light
numerous plants having significant medicinal properties
which were earlier unknown to scientific world
(Pushpangadan et al., 1988; Kaul et al., 1989;
Subramaniam et al., 1997, 1999). For instance, revealing
cardiac effect of the leaves of Digitalis purpurea that
were useful for treating dropsy is the best example of
folk use based herbal medicine (Cox, 1994). Patenting of
Jeevani, a drug from Arogyapaacha plant (Trichopus
zeylanicus spp. travancoricus) is another latest example
of drug, which could be developed from traditional
medicine based leads (Butani et al., 1994; Pushpangadan
et al., 1996; and  Singh and Lal, 2008).
Researches to find out scientific evidence for claims of
plants being used for traditional system of medicines
have been intensified for the last few years. It is estimated
that only less than 10% of 250,000 flowering plants in the
world have been examined successfully for their potential
medicines and still 90% remains to be explored. It is a
matter of great concern that around 60,000 species of
higher plants may probably become extinct by the year
2050 (Yogeeswaran, 2003).  This creates a sense of
urgency with regard to priority for preservation of
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medicinal plants.  Therefore, the traditional knowledge
along with its holistic and systematic approach supported
by experimental data can serve as an innovative and
powerful discovery engine for newer, safer and affordable
medicines in future (Samy et al., 2008). The prime
objective of the review is to discuss the current status of
herbal drugs in the management of human health care in
present times.
HERBAL DRUG SCENARIO IN INDIA
Plant products have been used to treat human diseases
since ancient times in different forms such as grinded
powder, poultice, decoction (ashava and arista) etc.  But
India has been among leading countries of the world in
utilizing plant kingdom for human disease management.
India has a large number of geographical zones providing
rich diversity of plant species,that has resulted in the
development of many systems of herbal medicine. Vedas
are considered as first documented record of human
knowledge conserving almost every aspect of the life.
Rigveda (4500-1600 B.C.) an old repository of human
knowledge describes 67 drug plants of great medicinal
value. India has a glorious past where fully developed
medical science was available before (3000-7000 B.C.)
with full description of disease symptoms,
pharmacogenesis and treatment. Ancient Indian Rishis
have given a first documented record in sanskrit scripts
in the form of Samhita. Two Samhitas namely Charak
Samhita (1000-800 BC) by Maharshi Charak and Shushrut
Samhita (800-700 BC) by Maharshi Shashurut are the base
line of Indian Medicine System. Maharshi  Charak
mentioned about 500 drug plants out of which, around
300 plants are now being used in the herbal
pharmaceutical industries in India. Ayurveda, an
important Indian medicine system, gives a detailed
description of about 700-800 herbs (Samy et al., 2008).
Other traditional medicinal sys-tems of India also employs
a large number of plant species e.g. Sid-dha (1121 spp.),
Unani (751 spp.) and Tibetan (337 spp.) Anonymous,
2004a).
Herbal drugs constitute a major share among all the
officially recognized systems of healthcare in India such
as Ayurveda, Yoga, Unani, Siddha, Homeopathy and
Naturopathy. These systems have rightfully existed side-
by-side with Allopathy and are not in ‘the domain of
obscurity’ (Vaidya and Devasagayam, 2007; Subramanian
et al., 2003). These systems are not folklore or traditional
herbal practices, but are basic axioms that serves as a
determinant of therapy (Vaidya, 1992; and Vaidya and
Devasagayam, 2007). A majority of medicines are being
prepared from the plants products in India with major
Pharmaceutical industries producing excellent herbal drug
preparations in both forms i.e., nutraceutical and
therapeutics. Some of the important Herbal Pharma
industries actively engaged in herbal preparations can
be quoted as, Gurukula Kangri Pharmacy (Haridwar),
Dabur, Himalaya, Charak, Hamdard, Baidyanath, Zandu etc.
There is a vast literature on Ayurveda available in different
languages i.e., Hindi, Sanskrit and several regional
languages along with English. Some of the recommended
literatures are Indian herbal pharmacopoeia (Handa,
1998,1999); Medicinal plants of India (Satyavati et al.,
1976);  and clinically useful drugs (Agrawal et al., 2005).
There are many references to Indian medicinal plants and
spices in a number of historical documents. For instance,
Indian Aloe is very widely used for cosmetic, medicinal
and nutraceutical purpose in India (Srivastava and Singh,
1996). Despite the global reputation of Aloe in dermato-
cosmetics, the potential as antiaging is still untapped
(Raina, 1996). Similarly, the plant Adhatoda vasica has
been extensively studied for cough (Shah and Chauhan,
1996) but its role in the bleeding disorders and
tuberculosis still needs significant research.Indian
medicinal plants are also a vast source of antioxidants
(Vaidya and Devasagayam, 2007). There are ayurvedic
formulations containing ingredients from medicinal plants
with antioxidant activities. Some of these are Amrita
bindu, Centalaplus, Chapparal, Geriforte, Jigrine, Liv-
52, Ophtacare, P55A, Sandhika and Tamra bhasma.
Recently Singh and Lal (2008) carried out ethnobotanical
survey in 130 localities of Lahaul-Spiti region in Western
himalaya and reported several plants used by the native
traditional practitioners in herbal formulations as a remedy
to cure rheumatism, liver and stomach disorders, and
various sexual ailments. These include Aconitum
heterophyllum (root and leaf; stomach disorders),
Aconitum rotundifolium (root; liver disorders and
rheumatism), Aphragmus oxycarpus (aerial parts; sexual
dysfunction), Artemisia maritime (root and seed;
stomach disorders and rheumatism), Bupleurum falcatum
(aerial parts; stomach disorders), Capparis spinosa
(shoot and flower; liver disorder and sexual dysfunction),
Carum carvi (seed; sexual dysfunction and liver
disorder), Crepis flexuosa (whole part; liver disorder),
Ephedra regeliana (leaf and fruit; rheumatism), Erigeron
borealis (leaf; stomach disorder), Gentiana
moorcroftiana (aerial part; liver disorder), Gentianopsis
detonsa (leaf and flower; liver disorder), Geranium
pretense (whole part; liver and stomach disorder),
Heracleum lanatum (root and leaf; stomach disorder and
rheumatism), Hippophae tibetana (flower; sexual
dysfunction and liver disorder), Lactuca rapunculoides
(leaf; stomach disorder), Lepidium latifolium (leaf and
flower; rheumatism), Plantago major (seed; stomach
disorder), Polygonum tortuosum (aerial part; liver and
stomach disorders), Rosa webbiana  (flower; sexual
dysfunction and liver disorders), and Scorzonera
divaricata (leaf and shoot; stomach and liver disorders).
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There are still a large number of plants and Ayurvedic
formulations whose activities need to be examined in
relation to their potential therapeutic and related
beneficial properties.
World Health organization has estimated that present
demand of medicinal plants is around US$ 14 billion per
year and the projected demand by the year 2050 would
be US$ 5 trillion. Medicinal plants related trade in India is
estimated to be around Rs. 550 crores per year
(Anonymous, 2004b). In the US$ 60 billion world trade in
medicinal plants, India’s total contribution is just around
US$ 100 million (Dubey et al., 2008). The export of herbal
medicines from India is of US$ 80 million. About 80% of
the exports from India to developed countries constitute
crude drugs instead of finished formulations resulting in
low revenue for the country. The medicinal plants
exported from India are Aconitum species (root), Acorus
calamus (rhizome), Adatoda vasica (whole plant),
Berberis aristata (root), Cassia augustifolia (leaf and
pod), Colchicum luteum (rhizome and seed), Hedychium
spicatum (rhizome), Heradeum candicans (rhizome),
Inula racemose (rhizome), Juglans regia (husk),
Juniperus communis (fruit), Juniperus macropoda
(fruit), Picrorhiza kurrooa (root), Plantago ovata (seed
and husk), Podophyllum emodi (rhizome), Pinica
granatum (flower, root and bark), Rauwolfia serpentina
(root), Rheum emodi (rhizome), Saussurea lappa
(rhizome), Swertia chirayita (whole plant), Valeriana
jatamansi (rhizome), Zingiber officinale (rhizome). Five
of these, i.e Glycerriza glabra, Commiphora mukul,
Plantago ovata, Aloe barbadensis and Azardica indica
are used in modern medicines. Others are used in 52 to
141 herbal formulations and Triphala (Terminalia
chebula, Terminalia belerica and Embelica officinalis )
is used in 219 formulation (Shrikumar and Ravi, 2007).
The major plants used by Indian Pharmaceutical
Industries  are Ajwain (Carum copticum), Akkalkadha
(Anacycus pyrethrum), Cardamomum green (Elettaria
cardamomum), Aloes (Aloe vera), Amala green (Emblica
officinalis), Anantmool (Hemidesmus indicus), Baheda
(Terminalia belerica), Brahmi (Bacopa monnieri),
Bhringraj (Eclipta alba), Chitrak (Plumbago zeylanica),
Dalchini (Cinnamomum zeylanicum), Daruhaldi (Berberis
aristata), Gajpippali (Scindapsus officiale), Guggul
(Commiphora wightii), Harda (Terminalia chebula),
Jambhul beej (Eugenia jambolana), Jatamansi
(Nardostachys grandiflora), Jeshthimadh (Glycyrrhiza
glabra), Ashwagandha (Withania somnifera), Kesar
(Crocus sativa), Clove (Syzygium aromaticum),
Pipramool (Piper longum), Shatavari (Asparagus
racemosus), Kalmegh (Andrographis paniculata) etc.
(Anonymous, 2004b). The major traditional pharma
sectors include Himalaya, Zandu, Dabur, Hamdard and
Maharishi etc. while, modern sector pharmaceuticals are
Ranbaxy, Lupin, Allembic and others are standardizing
their herbal formulations by chromatography techniques
like TLC/HPLC, Finger printing, etc and have launched
new projects regarding herbal formulations (Shrikumar
and Ravi, 2007).
In India, a large number of academic, industrial and
government institutes are actively engaged in drug plants
research  i.e., Central Council for Research in Ayurveda
and Siddha (CCRAS),  New Delhi; Indian Council for
Medical Research (ICMR), New Delhi; Central Council
for Research in Unani Medicine (CCRUM), New Delhi;
National Bureau of Plant Genetic Resources (NBPGR),
New Delhi; National Institute of Science Communication
(NISCOM), New Delhi; Regional Research Laboratory
(RRL), Jammu-Tawi; National Botanical Research Institute
(NBRI), Lucknow; Central Drug Research Institute
(CDRI), Lucknow; Central Institute for Medicinal and
Aromatic Plants (CIMAP), Lucknow; Banaras Hindu
University, Varanasi, Regional Medical Research Centre
(ICMR), Belgaum; Pharmaceutical Education and
Research Development (PERD), Ahmedabad; Indian
Medical Practitoners Co-operative Pharmacy and Stores
Ltd. (IMPCOPS), Chennai; Zandu Foundation, Mumbai;
Nicholas Piramal Research Centre (NPRC), Mumbai;
Pharmexcil, Hyderabad; Tropical Botanical Garden &
Research Institute (TBGRI), Thiruvantpuram; Botanical
Survey of India, Kolkata and Foundation for
Revitalization of Local Health Traditions (FRHLT),
Bangalore are  working  in close collaboration and have
initiated sizeable efforts for the development of herbal
based formulations for several chronic diseases
(Patwardhan et al., 2004; and Vaidya and Devasagayam,
2007).
MODERN SCIENTIFIC APPROACHES FOR
IMPROVEMENT OF DRUG EFFICACY OF HERBAL
DRUGS AND DRUG PLANTS (Fig.  2)
Since last decade of 20th century, several efforts have
been made to utilize the drug plants components
scientifically for getting better results in the field of
medicines. It is generally believed that the standardization
of herbal drugs is not required by traditional healers of
rural communities for primary health care. However, the
concept of good manufacturing practice for the
manufacture, processing, packaging and storage of
Active Pharmaceutical Ingredients (APIs) should also
be applied to herbal drug/drug plants, exactly similar to
that of modern medicine. The presence of different species,
varieties or different plant parts should be critically
controlled during the entire production process and such
adulteration should be avoided.
Selection of plant for potential therapeutic interest :
There are different approaches that can be used for
selecting plants of potential therapeutic interest
K.K. Gupta et al. / J. Appl. & Nat. Sci. 2 (1):165-181  (2010)
168
(Farnsworth and Bingel, 1977; Phillipson and Anderson,
1989; Vlietinck and Vanden Berghe, 1991; Kinghorn, 1994;
Farnsworth, 1996; and Verpoorte, 2000). Search for the
medicinal plants generally follow three main routes i.e.,
random, ethno (including ethnobotanical, ethnomedical
and ethnopharmacological) and ecological search. The
ethnobotanical, ethnomedical and ethnopharmacological
approach uses information obtained from ethnobotanical
survey such as the geographical distribution of the plant,
its abundance, whether it is threatened or endangered,
shrub/fast growing tree, easily cultivable, easily
identifiable (with minimum varieties) etc. Information such
as season of collection, plant parts to be used, and any
reported toxicity, is also required. Plants with medicinal
properties can also be selected using an ecological
approach, based on Zoopharmacognosy (a variation to
the ecological approach) which proposes the selection
of plant species regularly ingested by animals, mostly
primates for reducing pain, microbial or worm infestations
(Berry et al., 1995). Specifically, there are certain
differences in approaches when selecting plants for an
industrial or a rural application. The rural community
requires medicinal plants for their primary health care
and hence focuses more on selection of plants for
treatment of common diseases such as diarrhoea, malaria,
pneumonia, wound infections, etc. On the other hand,
pharmaceutical industry requires medicinal plants for
formulation of herbal drugs for commercial gain and hence
focuses more on urban problems such as metabolic
disorders, chronic diseases, and multi-drug resistance
among infectious pathogens. Whatever is the
requirement, the selection of plant should be based on
its therapeutic efficacy in terms of its effect on the
causative agent or on the host.
Taxonomical information: Strict directions have been
given by WHO (2000) that complete taxonomical
identification is an important factor during selection as
the plant species can play an important role in their
biological activity. Seeds for cultivation should be verified
botanically including genus, species, variety/cultivar/
chemotype and origin should be traceable. The same
applies to vegetatively propagated medicinal plants also
(Anonymous, 2002).
Collection of medicinal plants: The prominent mode of
obtaining medicinal plants is wild harvesting (Prasad and
Patnaik, 1998). Qualified individuals should be designated
to identify and verify collected drug plants/herbal drugs
and to supervise collectors. Collection of plants from
wild must be carried out in compliance with the existing
regional and national and/or national species
conservation legislation. Collection methods must not
damage the growth environment ensuring optimum
conditions for regeneration of the medicinal plant/herbal
drug harvested. Medicinal plants/herbal drugs from
species that are listed as endangered (CITES, Convention
on International Trade in Endangered Species of Wild
Fauna and Flora) must not be collected unless the
relevant competent authority has given its authorization
(Anonymous, 2002). Collection of medicinal plants
should not be done from places that are prone to or close
to sources of contamination such as areas where high
levels of pesticides or other possible contaminants are
used or found e.g. roadsides, drainages, mine tailings,
garbage dumps and industrial facilities which may
produce toxic chemicals or active pastures that may lead
to microbial contamination.
Scientific cultivation practices: The feasibility of
cultivating medicinal plants would, however, depend on
a number of factors such as the ability of the species on
the demand and market prices. Cultivation of medicinal
plants would seem as a commercially attractive option
because cultivation can reduce the dependence on
collection of plants from wild and thus have the potential
to save wild populations and conserve their genetic
diversity. Cultivation can lead to easy availability of
medicinal plants with multiple uses such as those with
both medicinal and commercial value. Moreover,
cultivation requires intensive care and management.
Introduction of non-indigenous plant species into
cultivation should be avoided. The starting material
(seeds/vegetatively propagated plant) should be as free
as possible from diseases and pests to ensure healthy
plant growth. Species resistant or tolerant to disease
should preferably be used. The use of genetically modified
plants or seeds must comply with regional and/or national
regulation. Drug plants should not be cultivated in soil
contaminated with sludge, heavy metals residues, plant
protection products or other chemicals etc. Utilization of
any chemicals in the growth or protection of the crop
should be kept to a minimum. Manure should be
thoroughly composted and free from human faeces. Other
fertilizing agents may be applied sparingly and in
accordance with the needs of a particular species.
Fertilizers should be applied in such a manner as to
minimize leaching. Irrigation should be controlled and
carried out according to the needs of the medicinal plant.
Water used in the irrigation should comply with regional/
national quality standards. Pesticide and herbicide
applications should be avoided as far as possible,
however when necessary, the minimum interval between
such treatment and harvest time must be consistent with
recommendations from the manufacturer of the plant
protection product and regional and/or national
regulation on maximum residue limits (Anonymous, 2002).
Harvesting of raw drug plants materials and processing :
As per guidelines (WHO, 2003), good collection practices
are necessary for collection of plant materials. Proper
season must be chosen for the harvesting of medicinal
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plants to ensure the best possible quality of both the
starting material as well as the finished product. Seasonal
variations can affect the chemical composition of the
plants and thus its biological activity. In most cases,
chemical constituents accumulate maximum at the
flowering time and decline at the beginning of fruiting
stage (Mendonca- Filho, 2006). The plant parts also play
an important role in harvesting since the level of
biologically active constituents can vary in different parts
at different stages of plant. For example, Kursar et al.
(1999) found that younger leaves of tropical rainforest
plants contained secondary metabolites that were either
present in very little quantities or totally absent in matured
leaves. Information about plant parts that are to be used
(roots, leaves, fruits, etc.) and whether these parts are
seasonal or replenishable should be obtained before
harvesting. Harvesting of drug plants should be done in
such a manner as to avoid wet soil, dew, rain or
exceptionally high air humidity. If harvesting is done
under wet conditions, then possible efforts should be
made to counter the adverse effects of high moisture level
on drug plants/herbal drugs. Cutting devices must have
minimum contamination from soil particles. Care should
be taken to prevent mixing of toxic weeds with harvested
plant material. Harvested plant material should not come
into direct contact with the soil and should be transported
under dry and clean conditions. Containers used in
harvesting must be clean and free of contamination of
previous harvests. Mechanical damage and compacting
of harvested plant material that would produce
undesirable quality changes should be avoided. There
should be some measures to prevent thermal degradation
of harvested material and protection from pests, mice/
rodents, livestock and domestic animals.
Processing, packaging and storage: Processing of plant
materials include washing, cutting before drying,
distillation etc. Prior to processing the material should
not be exposed directly to the sun except wherever
required. The plant materials should be protected from
moisture, rains and other deterioration conditions. The
inadequate means of processing make the raw material of
herbal drugs prone to contamination (Dubey et al., 2008).
Natural drying, i.e. drying without auxiliary energy either
in the field or in sheds, should only be considered for
drying of small quantities. In cases of mass production,
the use of technical drying applications is indispensable.
For preservation of active ingredients of plant material,
comparatively low drying temperatures are recommended.
The methods and temperatures used for drying have a
considerable effect on the quality of raw material of the
drug plant. Drying represents 30 to 50% of the total costs
in medicinal plant production (Qaas and Schiele, 2001).
Uniform drying of the drug plant/herbal drug is required
to avoid mould formation. Drying under direct exposure
to sunlight should be avoided unless specifically
required. Drying conditions i.e., temperature, duration
etc. should be selected according to the medicinal plant
part taken such as root, leaf or flower and the nature of
the active constituent for example essential oils. The
source of heat in direct drying should be limited to
butane, propane or natural gas. Packaging material should
not cause any contamination of the product, particularly
in case of fiber bags. Packaged dried medicinal plants/
herbal drugs should be stored in a dry and well-aerated
building to ensure good aeration. Aerated containers
are recommended during bulk transport of drug plants/
herbal drugs in order to reduce mould formation or
fermentation. However, other alternatives such as
sufficiently aerated transport vehicles and other aerated
facilities are also advisable.
Microbiological analysis of raw drug plants and
powdered herbal drugs: Raw drug plant materials are
being collected from different climatic conditions and
are stored in different storage conditions having different
levels of temperature and humidity. Whole plant system
appears prone for attack of heterogeneous groups of
microorganisms which may utilize the chemical
components of drug plants as food hence reduces the
drug efficacy ultimately effect the drug quality. Besides
this, some of them may be human pathogenic. Voluminous
information regarding the presence of microorganism on
raw and finished herbal industrial product is available.
As far as the effect of these organism on drug efficacy is
concerned only a very few fragmentary reports are
available. Some of the important contribution in the field
of microbial load and their effect on drug efficacy has
been reported by Prasad et al. (2002a, 2003 and 2007).
Considering above facts, microbiological examination of
raw and finished products has also been undertaken by
the researchers. But how many samples from each raw
and finished drug should be taken is not described
properly. This aspect is becoming more important both
in maintaining drug quality and prevention of human
pathogenic microorganism in the drug.
Phytochemical analysis for bioactive compounds:
Internal defense mechanism system of the plants is based
on enormous variety of small molecule antimicrobials.
Do plants synthesize target specific antibacterials is a
questions of thought. Large numbers of the plant
secondary metabolites have antimicrobial activity
against both Gram (+) positive and Gram (–) negative
bacterial species. Phytochemical studies of the drug
plant grown under different geographical conditions as
well as raw herbal drug material and  finish industrial
products, seems very necessary and it is a demand of
the time are necessary for standardization, which helps
in understanding the significance of phytoconstituents
in terms of their drug potency. Albeit, modern analytical
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Fig.1.  Steps involved in the phytochemical evaluation of herbal drugs (Ekka et al., 2008).
tools and techniques have facilitated in depth studies of
medically relevant compounds contained in different
plants, grown under different agroclimatic conditions.
More than one lakh small molecules compounds of plant
origin have been reported and a large number of among
them have shown their antimicrobial nature. Some plant
antimicrobials are produced at high level and owing to
their mechanism of action, need to be present at milimolar
concentration to offer adequate protection. since recent
literature has proved the antagonistic nature of the drug
plants which may be related with different compounds
present in the plant system and may act collectively
(synergetic) or separate individual. Therefore, it becomes
an important need of evaluation of phytochemicals in
both qualitative and quantitative and their
standardization also becomes imperative. Therefore,
currently the efforts have been made by
Ethanopharmacologists, Botanist, Microbiologist and
natural product chemist are combing the earth for
phytochemicals and “leads” which could be developed
for treatment of infectious disease (Cowan, 1999). The
phytochemical standardization encompasses all the
possible information generated with regard to the
chemical constituents present in an herbal drug. The
phytochemical evaluation for standardization purpose
includes Preliminary testing for the presence of different
chemical groups, Quantification of chemical groups of
interest, e.g., total alkaloids, total phenolics, total
triterpenic acids, total tannins, Establishment of
fingerprint profiles, Multiple marker based fingerprint
profiles, and Quantification of important chemical
constituents.
Standardization can be carried out by obtaining a chemical
fingerprint/profile or through bioactivity guided
fractionation. Chemical fingerprinting techniques are the
most commonly used techniques for standardization and
are obtained in terms of marker compounds. A marker
can be defined as a chemical entity, in the plant material
which may or may not be chemically defined and serves
as a characteristic fingerprint for that plant (Shrikumar
and Ravi, 2007). Various analytical techniques like TLC,
HPLC and HPTLC can be used to detect presence of
marker compound in the plant and also to quantify it to
ascertain the limits. A Biomarker on the other hand is a
group of chemical compounds which are in addition to
being unique for that plant material also correlate with
biological efficacy (Shrikumar and Ravi, 2007). The plant
extracts can also be standardized to class of compounds
e.g. ginsenosides in ginseng, kava lactones in kava, or
oxindole alkaloids in cat’s claw (Roman, 2001). Thin layer
chromatography (TLC) and HPLC are the most commonly
used methods for obtaining chemical fingerprints and
identification of the crude plant extracts. DNA
fingerprinting is another technique, which though still in
its early years, seems to be of immense potential in
identification of medicinal plants, particularly when
profiling the genotypic differences.
Evaluation of drug efficacy by testing the plants extracts
and its pure ingredients against known pathogen by
antimicrobial activity: Screening of the crude extract and
isolated phytochemicals based on their antagonistic
property/potency against known pathogen becomes
necessary to provide a scientific basis for validating the
utilization of medicinal plants. A great number of screening
programs are ongoing worldwide for new plant based
bioactive molecules. Several researchers have worked
on medicinal plants with activity against different
ailments. In recent years, the scientific evidence on the
effectiveness of herbal drugs has become the focus of
intense study in terms of their antimicrobial activity
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against certain microbial model in order to prove their
efficacy (Amagboul et al., 1985; Artizzu et al., 1995; Izzo
et al., 1995; Kubo et al., 1993; Sousa et al., 1991; Shapoval
et al., 1994; Kandhansamy and Anurachalam, 2008; Al-
Bayati, 2008; Czech et al., 2000). The emergence of MDR
strains has made it difficult for clinicians to empirically
select an appropriate antimicrobial agent (Walker, 2000).
Therefore, in vitro antimicrobial susceptibility testing
(AST) of the relevant bacterial pathogens, from properly
collected specimens, should use validated methods
(Anonymous, 2008). Plants extracts and phytochemicals
with known antibacterial activity may be of immense
importance in the therapeutic treatments (Indranil et al.,
2006). There is a number of antimicrobial susceptibility
testing (AST) methods available to determine bacterial
susceptibility to antimicrobials. Anonymous (2008),
suggested the methodology for the assessment of
antimicrobial susceptibility test which are as, ease of
performance, flexibility, adaptability to automated or semi-
automated systems, cost, reproducibility, reliability,
accuracy, the organism and the antimicrobials of interest
in that particular OIE member country and availability of
suitable validation data for the range of organism to be
susceptibility tested.
Disc Diffusion Method and Agar Well Diffusion Method
are the two most commonly used screens to determine
AST (Navarro et al., 1996). The diffusion of an
antimicrobial of a specified concentration from disks,
tablets or strips into solid culture medium is termed as
Disc Diffusion and diffusion through the holes punched
in the agar medium containing culture, termed as Agar
Well Diffusion, both methods mainly based on
determination of an inhibition zone. Disc Diffusion is
straightforward to perform, reproducible and does not
require expensive equipments. Its main advantages are
such as low cost, ease in modifying test antimicrobials
disks when required, can be used as a screening test
against large numbers of isolates, can identify a subset
of isolates for further testing by other methods, such as
determination of MICs.
The diffusion method is not appropriate for testing non-
polar samples or samples that do not diffuse easily into
the agar. In general the relative antimicrobial potency of
different samples may not always be compared mainly
because of differences in physical properties such as
solubility, volatility and diffusion characteristics in agar.
Dilution susceptibility testing methods are used to
determine MIC (Minimum Inhibitory Concentration). The
test compounds are mixed with suitable medium that has
previously been inoculated with the test organism. It can
be carried out in liquid as well as in solid media and the
growth of the microorganisms can be measured in a
number of ways. In agar dilution method, the minimal
inhibitory concentration (MIC) is defined as the lowest
concentration able to inhibit visible microbial growth. In
liquid or broth dilution methods, turbidity is most
frequently used. Turbidity can be estimated visually or
obtained more accurately by measuring the optical
density at 405 nm. In this case, the test samples not fully
soluble may interfere with turbidity readings, thereby
emphasizing the need for a negative control i.e. extract
dissolved in blank medium without microorganisms. The
liquid-dilution method also allows determination whether
a compound or extract has cidal or static action at a
particular concentration. Anonymous (2008) has
described the advantages of agar dilution method which
are as, the ability to test multiple bacteria, except bacteria
that swarm, on the same set of agar plates at the same
time, the potential to improve the identification of MIC
endpoints and extend the antibiotic concentration range,
and the possibility to semi-automate the method using
an inoculum-replicating apparatus.
Agar dilution methods also have some disadvantages
too, such as, if not automated they are very laborious,
require substantial economic and technical resources,
the plates prepared, normally should be used with in a
week, and the endpoints are not always easy to read nor
is the purity of inoculum easy to verify.
In general dilution methods are considered to be
appropriate for assaying polar or non-polar extracts or
compounds for determining Minimum Inhibitory
concentration (MIC) and minimum Bactericidal
Concentration (MBC)/ Minimum Fungicidal
concentration (MFC) values (Cos et al., 2006). In past
few years, a number of studies have been conducted in
different countries to prove such efficacy and the thrust
is still not over to find out the new source of antimicrobials
of plants origin that can be used as a source of synthetic
drugs in future. The effects of plant extracts have been
studied by a very large number of researchers all over
the world (Ates and Edrogrul, 2003; Edrogrul, 2002; and
Reddy et al., 2001). Belboukhari and Cheriti (2008)
reported antimicrobial effects of methanol extracts of
Launeae naudiculus against Staphylococcus aureus,
Escherichia coli, Pseudomonas aeruginosa,
Saccharomyces cereviceae, Candida albicans. Howaida
et al., (2002) have demonstrated the beneficial effects of
miswak crude extracts prepared from Salvadora persica
roots on oral pathogens i.e. Streptococcus mutans,
Lactobacillus acidophilus, Actinobacillus
actinomycetemcomitans, Actinomyces naeslundii,
Porphyromonas gingivalis, Prevotella intermedia and
C. albicans. Aboaba et al. (2006) demonstrated good
inhibition of ethanol extracts of Entada Africana on
various strains of E.coli 0157:H7 (EHEC). The
antimicrobial activities of some fatty acids of Turmeric,
Ginger root and Linseed was observed by Seher et al.
(2006), against various gram (+) positive bacteria and
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gram (–) negative bacteria i.e. Bacillus subtilis, S. aureus,
P. aeruginosa, E. coli, Klebsiella pneumoniae,
Enterobacter aerogens, Streptococcus species, Proteus
vulgeris, Listeria monocytogenes. They found that the
extract obtained from Linseed was most potent but in
general, a combination of linseed and ginger root was
found to be more effective than alone. Bhattacharjee
(2006), studied the antimicrobial potency of different
extracts (cold and hot aqueous and ethanolic extract) of
Argimone Mexicana against certain multidrug resistant
bacterial species i.e. B. subtilis, S. aureus, P. aeruginosa
and E. coli. The antibacterial activity of leaf essential
oils of Eucalyptus globus and Eucalyptus camadulaensis
was determined against S. aureus and  E. coli. by Ghalem
and Mohamed (2008).  Abukakar et al. (2008), studied the
phytochemical in crude aqueous extract of Tamarindus
indica and reported that major phytochemical
constituents were Saponins, Alkaloid and glycosides.
Further the extracts was evaluated for their antibacterial
potency against certain bacterial pathogens i.e. S. aureus,
E. coli, P. aeruginosa and Salmonella typhi  and extract
was found effective against all the bacterial pathogens.
Three strains of pathogenic bacteria (E. coli, K.
pneumoniae, and S. aureus) were treated with condensed
tannins (CT) in vitro. by Min et al. (2008). Increasing
prevalence of multidrug resistant strains of microorganism
has initiated the exploration of alternate antimicrobial
agent. The medicinal importance of Jatropha podagrica
(Hook) (Euphorbiaceae) in this respect is an attempt
was made to investigate the antimicrobial potential of
this plant by Bhushan et al. (2008) against S. aureus, E.
coli, and C. albicans.  Synergistic Activity of
combination of Amoxicillin and fruit solution of Cassia
fistula (CFF) was studied by Ali et al. (2007) against
(MDR) Salmonella enterica Serover Typhi (SEST). This
novel combination is named as Amoxy-cassia. In vivo it
is found to be non toxic at 1gm/body weight of mice.
Some medicinal plants used in Iran were evaluated for
antibacterial properties against Bacillus cereus, Bacillus
pumilus, Bordetella bronchiseptica, E. coli, K.
pneumoniae, Micrococcus luteus, P. aeruginosa,
Pseudomonas fluorescens, Serratia marcescens, S.
aureus and Staphylococcus epidermidis  by Bonjar
(2004).
In vitro Antibacterial Activity of Bougainvillea
spectabilis Leaves extracts were tested against S. aureus,
B. subtilis, Streptococcus faecalis, M. luteus, E. coli, P.
aeruginosa, S .typhii, K. pneumoniae, P. vulgaris, S.
marcescens, Shigella flexneri and Vibrio cholera by
Umamaheswari et al. (2008). In vitro Antimicrobial
Activity of the extract of Mitracarpus scaber leaves
which is an important ingredient of formulation of syrup,
was determined against E. coli, P. aeruginosa, S. aureus,
Sarcina lutea, C. albicans   and    K. pneumoniae by
Abere et al. (2007). They found that the growth of E.
coli, S. aureus, K. pneumoniae and C. albicans was
inhibited by the formulation at a minimum inhibitory
concentration of 75mg/ml. P. aeruginosa, and S. lutea
resisted all the concentrations of the formulation used.
The conclusion was that the extract from the leaves of
Mitracarpus scarber “Zucc” can be formulated into a
pleasantly tasting oral dosage form despite its bitter taste.
Bag et al. (2009) evaluated the antibacterial properties of
Chebulic myrobalan (fruit of Terminalia chebula Retz.)
extracts (cold aqueous, hot aqueous and ethanol) against
methicillin resistant S. aureus and trimethoprim-
sulphamethoxazole resistant uropathogenic E. coli. They
found that all the tested extracts showed to varying
degrees of strain specific antibacterial potential against
tested strains of which ethanol extract showed superior
activity against E. coli and hot aqueous extract against
S.  aureus. Cold aqueous extract exhibited the least
antibacterial activity against all the tested strains. These
promising findings suggest to antibacterial activity of
the plant material exhibited bioactive compounds against
multi-drug resistant bacterial pathogens and serving them
as an alternative antimicrobial agent against diseases
caused by these organisms.
Important contribution in the area of plant as
antimicrobial agent has been made by Prasad et al.
(2002b; 2006; 2007). They have not only evaluated
antimicrobial potency of certain drug plants against
certain microorganism but they also did find out the
possible application of the plant against the disease
mentioned earlier in the indigenous medicine system in
vitro.
Nogueira et al. (2008) studied the antimicrobial potency
of extracts and oil of certain drug plants i.e. Aleolanthus
suaveolens; Caryophyllus aromaticus; Cymbopogon
citratus; Matricaria chamomile; Pithecellobium
avaremotemo; Plectranthus amboinicus and Ruta
graveolens against the pathogens which were associated
with acute Otitis externa. They reported that
Staphylococcus aureus, Pseudomonas aeruginosa and
Candida  species were frequently found. Various
responses of oil was recorded against the test pathogens
associated with Otitis. P. aeruginosa was resistant to all
extract and oil. Growth of three strains (isolates), S aureus
was inhibited at 4%  and all Candida species at 01%
essential oil of Caryophyllus aromaticus and Matricaria
chamomile. According to them, test plants need more
further detail study for significant results.
The use of plants based medicines has been increasing
all over the world, not only for infectious diseases but
also for other problems like cancer, high blood pressure,
allergies and for general well being (Eisenberg et al., 1993).
Most of the diseases like diabetes, heart diseases, cancer,
psychiatric disorders, are multifactorial. Plants with
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complex phytochemical  mixtures have advantage over
single molecules in treating such diseases, with an added
advantage of being devoid of toxic side effects. A number
of such studies have been reported from all over the
world including the anticoagulant properties from the
seed of Cassia obtusifolia against platelet aggregation
by arachidonic acid (AA), collagen, platelet activating
factor (PAF), and thrombin by Jeon et al. (2009). and the
anticancer effect of Dangyuja (Citrus grandis Osbeck)
leaf extract was investigated using SNU-16 human gastric
cancer cells by Moon et al. (2009), in which herbal
remedies are used for the treatments of non-infectious
diseases. The use of herbal preparations for the treatment
of Alzheimer’s diseases has also been reported by Neto
et al. (2006).
Herbal medicines have also been used in the treatment
of behavioral and psychological symptoms of Dementia
(BPSD) but with various responses. Randomized
controlled studies assessing AD in individuals older than
65 years were identified through searches of MEDLINE,
LILACS, Cochrane Library, dissertation abstract (USA),
ADEAR (Alzheimer’s Disease Clinical Trials Database),
National Research Register, Current Controlled trials,
Centerwatch Trials Database and PsychINFO Journal
Articles. The search combined the terms Alzheimer
disease, dementia, cognition disorders, Herbal,
Phytotherapy (Neto et al., 2006). These herbs and
formulations have demonstrated good therapeutic
effectiveness but these results need to be compared with
those of traditional drugs (Kitula, 2007).
Scientific approaches in herbal pharmaceutical
industry: There are about 7000 firms in the small scale
sector manufacturing traditional medicines with or
without standardization but the authenticity, quality and
purity of herbal drugs are important factors from
standardization point of view and cannot be neglected.
However, major traditional sector pharmas namely
Himalaya, Zandu, Dabur, Charak etc are standardizing
their herbal formulations by chromatography techniques
and fingerprinting. The quality and purity standards are
established in pharmacopoeia which prescribes
structural, analytical and physical standards for the drugs
(Ekka et al., 2008). Most of the drugs have definite specific
chemical constituents to which their biological or
pharmacological activity is attributed. Qualitative and
quantitative characterization of the active ingredient
should be assayed using biomarkers and the mixture
should be analyzed to develop finger print profile. For
isolation of compounds, chromatography techniques
such as column chromatography, partition
chromatography, thin layer chromatography, GLC, HPLC
and HPTLC are used.
While manufacturing, the critical examination and
identification of herbal drugs is required because of
diversity in their chemical constituent therefore to over
come this problem all the pharmacopoeia have certain
standards. Drugs are manufactured from different raw
materials by using different methods or process. Some
impurities are incorporated into the material during the
manufacturing process. In general, the possibilities of
addition of impurities during the process of drug
manufacturing through different manners/ways can not
be ignored. These impurities added in the process may
be of different in nature. Therefore a strictly guide lines
prepared by Indian, indigenous pharmacopoeia must be
followed. Final testing of finished product is made in the
quality control laboratories. These tests are designed to
determine compliance with specifications. Thus the
testing of the finished product for compliance with
predetermined standard prior to release of the product
for packaging and subsequent distribution is a critical
factor for quality assurance. This testing along with in
process testing, assures that each unit contains the
amount of drug claimed on the label, that all of the drug
in each unit is available for complete absorption, that the
drug is stable in the formulation in its specific final
container closure system for its expected shelf life and
that dosage units themselves contain no toxic foreign
substances. The label of herbal medicine should have all
the particulars required by national regulations.
Preclinical and clinical approaches: Preclinical testing
helps in collection of important efficacy and safety data
before clinical trials.  The preclinical evaluation involves
documentation and testing of pharmacological efficacy
in vitro (cells) and studies of toxicology, specificity,
biopharmaceutical properties and drug interactions of
medicinal plants. The therapeutic effect of the plant, the
efficacy and/or the mechanism of action including cell
interactions, cell-environment interactions, intracellular
activity, and genetic studies can be determined by
preclinical studies. The advantage of these studies is
that one can easily study and compare the efficacy of
different plants in a cost effective manner and design
rational drug combinations and it requires proper
designing of screening assays. The basis for designing
a screening assay is the identification of valid target. 30-
40% of experimental drugs fail due to an inappropriate
target (Butcher, 2003) and hence it is important to develop
new screening assays with more appropriate targets.
Though the cell-based assays are more challenging than
with biochemical assays due to requirement of significant
investments in cell culture infrastructure (Moore and
Rees, 2001). The current trend is shifting towards cell-
based assays because of multiple advantages, It can
provide biologically more relevant information on the
nature of the activity (Moore and Rees, 2001; Johnston,
2002), information regarding cellular membrane
permeability and cytotoxicity.
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Approaches that are used for studying the
pharmacological effects of medicinal plants are: use of
single bioassay for screening multiple plants and use of
multiple bioassays for studying single plant. However,
this approach is not always appropriate as plants exhibit
their efficacy against infectious diseases by mechanisms
other than antimicrobial activity. Immunological assays
and synthetic antigens are used for screening of plants
for immunity-enhancing properties. There are certain
limitations of preclinical studies like Suitable
pharmacological models have not yet been developed
for many common diseases with unknown or multi-
factorial origins (Hamburger and Hostettmann, 1991),
Some compounds which show good activity in vitro may
be metabolized in vivo into inactive metabolites.
Alternatively, extracts may only show in vivo activity
due to the metabolism of inactive compounds into active
forms (Farnsworth, 1993), The pharmacological
investigation of drug interactions in multi-compound
preparations is difficult due to the presence of
constituents from several plants where some plants may
show less specific activity and some plants may have
been added to reduce the toxicity of the more
therapeutically effective plants (Taylor et al., 2001).
 The pharmacological effects of medicinal plants before
they can be integrated into conventional medical practice
are conformed through Clinical studies. Well established,
randomized controlled clinical studies facilitate the
acceptance of herbal medicines in different regions. These
studies should be carried out on the basis of information
obtained from relevant literature or traditional medical
practitioners. The principles applied for clinical studies
should be followed when testing a new herbal preparation
(WHO, 2000). The methods and guidelines used for
clinical validation of modern medicines must be applied
to herbal products even though the latter has a holistic
approach to treatment. However, conventional concepts
of clinical research design are difficult to apply when
used to evaluate various systems and practices of
traditional medicine (WHO, 2000). The reason behind the
fact is that the herbal remedies are individualized
therapies hence depend on the proficiency of medicinal
practitioners. In some cases, Clinical studies must be
adapted to deal with the specifics of herbal medicines.
The number of patients required for undertaking clinical
trial of medicinal plants is large and the increase in patient
number also increases the time commitment and the
expenses involved. Therefore only a limited number of
plants can be subjected to clinical trials.
Toxicological evaluation: Toxicological evaluation of
medicinal plants has been neglected since prolonged and
apparently uneventful use usually is considered as a
testimony of its safety. However, a history of traditional
usage is not always a reliable guarantee of safety as it is
difficult for traditional practitioners to monitor delayed
effects (e.g. mutagenicity), rare adverse effects, and
adverse effects arising from long-term use (Ernst, 1998).
The use of herbal preparations may also lead to
hypersensitivity reactions ranging from transient
dermatitis to anaphylactic shock (Ernst, 1998). Many
widely used medicinal plants have been reported as
possible causes of long-term  liver and kidney diseases
The widespread use of Scenecio, Crotalaria and
Cynoglossum has been reported in the occurrence of
liver lesions and tumours, lung and kidney diseases in
certain areas of Ethiopia. Therefore it becomes necessary
to carry out toxicological studies, both short term and
long term. Toxicological studies should include tests such
as acute, subchronic and special toxicology that are
impossible to detect clinically such as immunotoxicity,
genotoxicity, carcinogenicity and reproductive toxicity
(Remirez, 2006).
DRUG PLANTS AS A POTENT THERAPEUTIC FOR
SOME CHALLENGING HUMAN DISEASES
Currently it is obvious that a large number of human
diseases have not still been properly cured/ managed by
the modern medicines even after spending a lot of money
and involvement of a large number of team workers. The
efforts made in this direction could not succeed and it
forced to find out some suitable substitute from the
nature. Plants which have served since birth of human
race on the globe has become again a hope for such kind
of diseases. There are reports that scientists could either
isolate the components from the drug plant origin which
inhibits the growth of concerned organism by changing
in microbial physiology or by changing their metabolic
products. There are certain reports in which it has been
mentioned that drug plants are effective in controlling
some fatal human diseases.
Swayamjot et al. (2005), studied the in-vitro cytotoxic
and apoptotic activity of Triphala on cancer cell lines
using Shionogi 115 (S115) and MCF-7 breast cancer cells
and PC-3 and DU-145 prostate cancer cells as models.
They found that acetone extract of “Triphala” was found
to show significant effect on these cancer cell-lines and
the effect was similar on all cancer cell lines. Khantamat
et al. (2004), studied the effect of different parts of
Momordica charantia against MDR which was due to
over expression of 17 OK Da-p-glycoprotein (Pgp) which
was responsible for less deposition of the drug in the
cancerous cells could be initiated by the leaf extract of
above plant against MDR human cervical carcinoma KB-
V1 cell (high Pgp expression). They found that the leaf
extracts increased the intracellular accumulation of [³H]-
Vinblastine in KB-V-1 cells. Lin et al. (1999) study the
cancer chemoprevention by tea polyphenols through
mitotic signal transduction blockade. They found that
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the major tea polyphenol (-)-epigallocatechin-3-gallate
(EGCG) suppress extracellular signals and cell
proliferation through epidermal growth factor receptor
binding in human A431 epidermoid carcinoma cells; EGCG
also blocks the induction of nitric oxide synthase by
down-regulating lipopolysaccharide-induced activity of
the transcription factor NFB in macrophages.
A Chinese drug plant, Rhus chinesis which is used as a
folk medicine in china was evaluated against HIV-1 by
Wang et al. (2005). They extracted the components in
different solvent i.e. petroleum ether, ethyl acetate,
butanol and water. They found that extract of petroleum
ether could inhibit syncytium formation and HIV-1 p24 at
non toxic concentration (EC50 ) were 0.71 and 0.93 ìg/ml.
although it was quite effective and therapeutic index (TI)
WAS 100% but could not show inhibitory activity iin
HIV-1 recombinant RT and entry on the host cells but the
possibility are there about post steps or target by RC-1
extract may be further investigated for their future
possibilities in HIV-1 infection.A screening study of
organic and aqueous extracts of Southerlandia
frutescens(L.) and Lobostemon trigonus for Anti-HIV
activities was carried out by Harnett et al. (2005). They
found that the Sutherlandia extracts contain inhibitory
compounds active against HIV target enzymes, while
aqueous Lobstemon leaf extracts contain a potent HIV-1
RT inhibitor, thus showing a potential mechanistic action
of these plants in aiding HIV- positive patients. Curcumin,
an extract of Turmeric, Curcuma longa L., which has
been used in the treatment of arthritis, diabetes and as a
anti-inflammtory agent for centuries, has been studied
for anti-rheumatic activity in synovinocyte, angiogenesis
inhibition in smooth muscle cells and for anticancer
potential in mouse lymphoma cells in vitro and for
hypoglycemic activity by oral gavage in streptozotocin
(STZ) –diabetic rats in vivo alone and in combination
with vanadyl ion in the form of vanadyl curcumin complex
(VO(cur2 ) by Thompson et al. (2004). They found that
vanadyl curcumin complex (VO(cur2 ) was more effective
as an anticancer agent, more than twice effective as an
anti-arthritic agent and four times effective in inhibitory
smooth muscle cell proliferation, compared to curcumin
alolne along with no negative symptoms during a long
treatment period of one month at doses up to 2.00 mmol
kg day. Pyricularia oryzae mycelia, a phytopathogenic
fungus responsible for rice blast, was developed for
screening of antifungal and antineoplastic agents from
fungus metabolites and traditional Chinese medicine
wikstroemia indica by Ke Hu et al. (2000). They isolated
one biscoumarin i.e. daphnoretin, one lignin i.e.
nortrachelogenin, and four biflavonoids i.e. genkwanol
A, wikstrol A, wikstrol B, and dephodorin B, from the
roots of wikstroemia indica by bioactivity guided
fractionation with the P.oryzae bioassay. They found that
all the four isolated biflavonoids showed moderate
activity against microtubule polymerization with IC50
values of 112 ± 4, 131 ± 3, 184 ± 6, 142 ± 2 ìM in vitro. All
the isolated compounds induced morphological
deformation of P.oryzae mycelia with MMDC values of
6.8 ± 1.3, 31.3 ± 1.8, 45.8 ± 0.5, 70.1 ± 2.4, 52.3 ± 0.9 and
73.7 ± 1.6 ìM and compounds nortrachelogenin,
genkwanol, wikstrol B and daphoderin B were moderetly
active against HIV-1 invitro. These findings of bioactivity
of all the isolated compounds support the antifungal,
antimitosis and anti HIV-1 uses for W.indica roots.
Magnosalin. A neolignan isolated from Japanese Sine-
medicine ‘Shin-i’ (flos magnoliae) has been demonstrated
to inhibit the proliferation of synovial cell in the
pathogenic state of RA (rheumatoid arthritis) by
Kobayashi et al. (1998). In this study the inhibitory effect
of magnosalin on cell proliferation were compared with
those of anti-rheumatic sdrugs in RA models, MRL/1pr
and CIA mice and RA patients. The effects of magnosalin
on the cytokine stimulated proliferation of synovial cells
in C57 BL/6J mice were also examined to investigate the
mode action of magnolasin in the pathogenic state of
RA. They found that 2.39-23.9 ìM of magnosalin inhibited
5% fetal bovine serum (FBS)- Stimulated [3 H] thymidine
incorporation into the synovial cells in the MRL/1pr mice.
The effect of magnosalin was greater than that of
hydrocortisone, bucillamine, and magnoshinin (another
comp. from shin-i) but found weaker than that of
corticostrone. In case of FBS – induced thymidine
incorporation into the cells of the CIA mice and RA
patients, the effects were greater than those of control
mice and osteoarthritis patients. The clinical efficacy of
traditional anti-rheumatic herbal medicines of china on
acutr and serve arthritis or immune disease was
investigated by Chou and Chang, (1998). In this study,
four herbal formulations i.e. (SYGTT), (SISTY), (SILAS),
(MSTYGT) and one herb i.e. Triptergium willfordii (T2)
were tested invotro to determine their effects on
prostaglandin E2 (PGE 2 ) and interleukin 2 (IL2). The
peripheral blood mononuclear cells from healthy
formulations and one herb in different concentration with
and without mitogen stimulation. The culture supernatant
were subjected to enzyme immunoassay for the
measurement of PGE2 and IL2. They found that PGE2
release is inhibited by MSYGT at 500 ìg/ml and by
SYGTT, STSTY, STLAS at 100 ìM. However, similar
response was expressed by T2 at 2 ìg/ml. For IL2 inhibition,
the concentrations of these herbal formulations were
exceeding 100 ìg/ml. The anti-inflammatory property of
total ethanol extract (TEE) , three alkaloid fractions, and
oxyacanthine isolated from Berberis vulgaris roots, a
comparative study was carried out by Ivanovyska and
Philopov, (1996).  They found that the TEE was the most
effective in a chronic inflammatory model of adjuvant
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arthritis. The anti-inflammatory and anti ulcer activity of
Teucrium buxifolium was studied by Punter et al. (1997)
and Teucrium buxifolium species have displayed
significant antiulcer and cytoprotective activity.
Inhibition of Adenovirus infection and adenain by green
tea catechins was reported by Weber et al. (2003). Green
tea catechins have been reported earlier to inhibit
proteases involved in cancer metastasis and infection
by influenza virus and HIV (Weber et al.,2003 ).
APPLICATION OF DRUG PLANTS OTHER THAN
THERAPEUTICS
Drug plants as nutraceuticals: A large number of drug
plants have been used since ancient times as good source
of various components needed for good human health
and can be called as functional food. These functional
foods promote better health with good immunity which
helps to reduce the chances of illness as well as from
chronic illness. Certain ingredients which may be
consider as a functional foods are dietary fibers, vitamins,
minerals, oligosaccharides, essential fatty acids, lactic
acid bacteria (curd), and antioxidants.
Drug plants as a major source of an antioxidant
components: A large number of drug plants (different
parts and their products) are being generally used in diet
such as different spices, Turmeric, Coriander, Clave,
Cardamom, Cinnamon, Saffron, Ginger, Onion, Garlic,
and Chilies etc. since last decades a tremendous interest
have been found among the scientist about possible role
in prevention of  human diseases generated by oxidation
of different components by reactive oxygen species
(ROS) and free radicals.
In biological system, oxygen give rise to large number of
free radicals and other reactive species collectively called
as reactive oxygen species (ROS). Another grouped
reactive species are termed reactive nitrogen species
(RNS). In normal condition, both remain under controlled
level by antioxidant defense. But under certain adverse
condition they may facilitate pro-oxidants which results
oxtant stress. Under oxidative stress, cellular damage
starts and degree of cellular damage will be depend on
intensity of oxidative stress.
The discovery of the inhibition of the lipid per oxidation
by some phenolic compounds during the late 1940’s,
contributed to the application of synthetic oxidation in
the food industry. A large number of synthetic oxidants
could be produced such as butylated hydroxyanisole
(BHA), butylated hydroxytoluene (BHT), propyl gallate
(PG) and others have been dominant since their
introduction. But due to the side effects of these synthetic
antioxidants, more concentration has been made to get
natural antioxidants from the plant sources. It has been
found that herbs are not only the rich source of potent
antioxidants as well as retard lipid oxidative rancidity in
foods (Olukemi et al., 2005; Sherwin, 1990). Medicinal
plants possessing natural antioxidants polyphenolics
such as anthraquinones, flavonoids, aromatic acids, and
tannins have been shown to have ROS scavenging and
lipid peroxidation prevention effects. (Olukemi et al., 2005;
Hong et al., 1994).
Mechanism of antioxidant action: Antioxidant are
compounds that help to inhibit the many oxidation
reactions caused by free radicals such as singlet oxygen,
superoxide, peroxyl radicals, hydroxyl radicals and
peroxynitrite thereby preventing or delaying damage to
the cells and tissues. their mechanism of action include
scavenging reactive oxygen and nitrogen free radical
species, decreasing the localised oxygen concentration
thereby reducing molecular oxygen’s oxidation potential,
metabolizing lipid peroxides to non-radical products and
chelating metal ions to prevent the generation of free
radicals. In this way antioxidants limits the free radical
damage from Oxidizing Low Density Lopoprotein (LDL)
cholesterol, which may increase the risk of
atherosclerosis, promoting platelet adhesion, which can
lead to thrombosis thereby increasing the risk of heart
disease or stroke, damaging the cell’s DNA, which may
lead to cancer, blocking the normal endothelial cell
function and vasodilation in response to nitric oxide, a
potential mechanism for heart disease and cancer,
triggering inflammation and impairing immune function
(Olukemi et al., 2005; and Lakenbrink et al., 2000).
Recommendation for future planning
Twenty first century seems to face a major global health
management problem due to developing antibiotic
resistance in bacterial pathogens. Since a large number
of reports are regularly coming regarding appearance of
newer multidrug resistant bacterial pathogens which have
limited the use of cheap and old antibiotics which were
quite effective earlier. In order to obtain new antimicrobial
compounds specially from the plant world, it becomes
an imperative to make a continuous researches in this
direction. Further, the mechanism of development of
resistance among the pathogens seems an important
aspects and needed much attention to understand the
resistance development process in order to make an
effective plan. In making the future strategies to over
come these problems, the molecules of antibacterial
obtained from the plants should be placed in three separate
groups i.e. Traditional antibiotics, Multidrug resistance
inhibitors/killers and Compounds that target the virulence
of the pathogens and more emphasis should be
concentrated with these objectives. It is obvious that
only the plant world would serve as a source of new
antimicrobial compounds and resistance modifying agent
in future, therefore it is an urgent need of the time to
concentrate the researches in the above cited areas for
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making a successful management of health problems.
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